Skip to content

B-256 DAEDALUS: a de novo artificial intelligence co-designed bioinformatics pipeline for infectious disease next-generation sequencing applications

Oct 2026 · Clinical Chemistry · Vol 72 · 0 citations

TL;DR

This proof-of-concept pipeline supports both on-board reference-based and reference-independent sequence interpretation in a clinically relevant framework and demonstrates that complex bioinformatics workflows for infectious disease NGS analysis can be developed through iterative human-AI collaboration without reliance on specialized bioinformatics personnel or high-performance computing infrastructure.

Abstract

One of the primary barriers to implementing next-generation sequencing (NGS) in clinical laboratories is the perceived need for a dedicated bioinformatician and/or costly commercial analysis software. As a result, many laboratories lack the flexibility to design, validate, and adapt NGS analysis workflows tailored to their specific diagnostic needs. This proof-of-concept study describes a de novo artificial intelligence co-designed bioinformatics pipeline for infectious disease next-generation sequencing applications (DAEDALUS). This workflow addresses a critical rate-limiting step in clinical NGS adoption by enabling autonomous data analysis without reliance on specialized bioinformatics software, personnel, or high-performance computing infrastructure. A total of eight contrived clinical specimens representing bacterial, mycobacterial, and fungal infections were prepared. DNA was extracted using the Maxwell RSC instrument and Genomic DNA kit, followed by amplification with universal degenerate primers targeting 16S rRNA, hsp65, ITS, and D1/D2 regions. Amplicons were sequenced on an Illumina MiSeq platform (2×250 bp). DAEDALUS was developed through more than 100 iterative conversational prompts with a custom generative pre-trained transformer (GPT) configured to assist with bioinformatic scripting. Domain expertise guided all analytical design decisions, while the GPT provided support for Python code generation, debugging, refactoring, parameterization, and documentation. All scripts were executed within a Spyder integrated development environment on standard consumer computing hardware. The GPT-assisted, human-directed development process produced a fully functional, standalone bioinformatics pipeline capable of processing paired-end infectious disease NGS data. The pipeline underwent more than twenty major revisions, including eight complete script rewrites. DAEDALUS generated three primary outputs: (1) on-board reference-based mapping against publicly available databases, (2) representative FASTA sequences for NCBI BLAST, and (3) the most abundant single sequence for reference-independent BLAST analysis. Consolidated quality-control outputs included read counts, Q-score summaries, read-length distributions, and mapping summaries. Across eight contrived specimens, on-board mapping yielded the expected genus- and species-level identifications in 87.5% and 50% of cases, respectively, whereas BLAST analysis of the representative or most abundant sequence yielded expected species-level identification in 87.5% and 100% of cases, respectively. Taken together, these results demonstrate that complex bioinformatics workflows for infectious disease NGS analysis can be developed through iterative human-AI collaboration without reliance on specialized bioinformatics personnel or high-performance computing infrastructure. DAEDALUS illustrates the feasibility of using generative artificial intelligence as a development partner to lower technical barriers that have historically limited clinical NGS adoption. By integrating adaptive analysis logic, transparent outputs, and comprehensive documentation, this proof-of-concept pipeline supports both on-board reference-based and reference-independent sequence interpretation in a clinically relevant framework. Future refinement of DAEDALUS will focus on establishing standardized interpretive criteria with the ultimate goal of subsequent clinical validation.

View source

Similar papers

Open access Nov 2026

Experimental and computational insights for broad, metagenomic next-generation sequencing-based biodetection in complex environments

Metagenomic next-generation sequencing offers a powerful approach for broadly detecting known and emerging pathogens and is being applied to an expanding set of applications from infectious disease diagnostics to biodefense. However, the ability to sequence a sample of interest does not necessarily mean that the result...

Jennifer L. Mallek, A. Mannion, A. Xiao et al. · 0 citations
Oct 2026

Optimizing Pathogen Detection in Clinical Metagenomics: A Comprehensive Benchmarking of Bioinformatic Pipelines for Single-End Short Reads.

Metagenomic next-generation sequencing for identifying pathogens has been increasingly utilized as a diagnostic tool. Prior research mostly emphasizes the selection of classification software based on reads above 100bp, neglecting the influence of sequencing data pre- and post-processing stages. Independently assessmen...

Jun Ma, T. Hao, Ya-Hong Bai et al. · 0 citations
Open access Oct 2026

A Pipeline for Mapping FDA-Approved Nucleic Acid Amplification Tests (NAATs) to NCBI Taxonomy

Background The United States Food and Drug Administration (FDA) catalogs in vitro diagnostics, including Nucleic Acid Amplification Tests (NAATs), using unstructured clinical terminology. Because these regulatory labels often diverge from standardized biological taxonomy, they obstruct automated post-market surveilla...

M. Duval · 0 citations
Oct 2026

B-324 Pgxtools: a comprehensive platform with multiple bioinformatics pipelines for next generation sequencing based pharmacogenomics workflows

Pharmacogenomics (PGx) testing supports personalized drug treatment based on a patient’s genetic profile, with the goal to optimize drug selection/dosing, prevent adverse drug reactions and improve patient safety. Several single gene-drug-pair tests have become part of the standard-of-care. Multigene-panel-based...

D. Yuan, Jun Hyuk Park, Olivia Tesolin et al. · 0 citations
Open access Nov 2026

MicrobeRT: A Framework and Suite of Fine-tuned Language Models for Genomic Sequences

Accurate and reproducible metagenomic analysis is essential for effective infectious disease surveillance. Targeted diagnostics such as culturing, antigen assays, and multiplex PCR panels identify only predefined organisms and can fail to identify atypical or novel infections. Shotgun metagenomics offers hypothesis-fre...

V. Narayan, Brian B. Merritt, Sanjeevani Choudhery et al. · 1 citation
Review Open access Oct 2026

Artificial Intelligence in Virus Detection: From Metagenomic Discovery to Clinical Decision Support and Population Surveillance

Artificial intelligence (AI) is increasingly central to modern virus detection, particularly as metagenomic next-generation sequencing (mNGS) expands diagnostic and surveillance capabilities beyond targeted assays. This paper reviews how AI supports virus detection across three interconnected levels. The metagenomic la...

Georgia Liakopoulou, A. Koutsiaris · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.